Biểu đồ giá cổ phiếu 03692.HK
HANSOH PHARMA (03692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$37.1
-0.32%
$-0.11
Thị trường đóng cửa: May 07, 16:00:00 HKT
Quay lại
Hansoh Pharmaceutical Group Company Limited (03692.HK)
Thống kê chính
Giá đóng cửa trước
$37.22
Giá mở cửa
$37.22
Phạm vi ngày
$36.96 - $38.02
Phạm vi 52 tuần
$15.96 - $44.22
Khối lượng
5.0M
Khối lượng trung bình
8.1M
Tỷ suất cổ tức
--
EPS (TTM)
0.89
Vốn hóa thị trường
$220.5B
HANSOH PHARMA là gì?
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
